Guardant Health Inc. (NASDAQ:GH) finished Friday with a subtraction of -$0.49 to close at $35.59, a downside of -1.36 percent. An average of 1,190,760 shares of common stock have been traded in the last five days. There was a fall of -$2.23 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 1,374,625 shares traded, while the 50-day average volume stands at 1,782,422.
GH stock has decreased by -8.37% in the last month. The company shares reached their 1-month lowest point of $34.98 on 08/03/23. With the stock rallying to its 52-week high on 07/27/23, shares of the company touched a low of $20.67 and a high of $62.75 in 52 weeks. It has reached a new high 20 times so far this year and achieved 30.85% or $8.39 in price. In spite of this, the price is down -43.28% from the 52-week high.
Insider Transactions
GH stock investors should be aware that Guardant Health Inc. (GH) stock had its last reported insider trading activity 58 days ago on Jun 15. In this transaction, the insider spent $103,863. Chief Information Officer, Kalia Kumud, disposed of 6,500 shares at a price of $31.92 on Mar 03. The insider now owns more than $207,466 worth of shares. Prior to that, Chief Information Officer Kalia Kumud went on to Sale 3,125 shares at $51.87 each on Nov 15. An amount of $162,082 was transacted.
Valuation Metrics
Guardant Health Inc. (GH) stock’s beta is 0.87. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 8.12.
Financial Health
The quick ratio of Guardant Health Inc. for the three months ended June 29 was 5.20, and the current ratio was 5.40, indicating that the company is able to meet its debt obligations. Guardant Health Inc.’s EBITDA margin for the year ending June 29 is -110.98%. Its gross profit as reported stood at $293.21 million compared to revenue of $449.54 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Guardant Health Inc.’s return on assets was -39.20%.
Earnings Surprise
For the three-month period that ended June 29, Guardant Health Inc. had $953.78 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$72.77 million in the quarter, while revenues of -$133.53 million were shrunk -215.28%. The analyst consensus anticipated Guardant Health Inc.’s latest quarter earnings to come in at -$1.18 per share, but it turned out to be -$0.67, a 43.20% surprise. For the quarter, EBITDA amounted to -$110.42 million. Shareholders own equity worth $117.69 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Guardant Health Inc. (GH) price momentum. RSI 9-day as of the close on 11 August was 38.40%, suggesting the stock is Neutral, with historical volatility in this time frame at 44.64%.
As of today, GH’s price is $36.49 -5.90% or -$2.23 from its 5-day moving average. GH is currently trading -7.12% lower than its 20-day SMA and +37.15% higher than its 100-day SMA. However, the stock’s current price level is +21.38% above the SMA50 and -16.69% below the SMA200.
The stochastic %K and %D were 24.17% and 34.07%, respectively, and the average true range (ATR) was 1.55. With the 14-day stochastic at 13.86% and the average true range at 1.53, the RSI (14) stands at 43.65%. The stock has reached -0.62 on the 9-day MACD Oscillator while the 14-day reading was at -1.28.
Analyst Ratings
The consensus rating for Guardant Health Inc. (GH) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell GH, while 3 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 17 others rate it as a “buy”.
What is GH’s price target for the next 12 months?
Analysts predict a range of price targets between $40.00 and $85.00, with a median target of $53.00. Taking a look at these predictions, the average price target given by analysts for Guardant Health Inc. (GH) stock is $55.24.
